Plain-English translation of NCT05935189 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are building a tissue registry—a collection of samples and health information—from people who have been diagnosed with hepatocellular carcinoma (a type of liver cancer). By gathering tissue samples, blood samples, and detailed medical records from 500 patients of Armenian descent, the study aims to understand the genetic and biological factors that contribute to this cancer.
Liver cancer happens at high rates in Armenia, but researchers still don't fully understand all the reasons why some people develop it. This registry will help scientists identify new risk factors and develop better ways to prevent, detect, and treat the disease in the future.
You likely qualify if…
You likely don't qualify if…
If you join, you will be asked to provide a tissue sample (from a biopsy you may already have had), a blood sample, and information about your medical history and current health. Researchers will also collect your imaging results and may study your gut bacteria. The study is happening across eight hospitals and medical centers in Armenia, and researchers aim to enroll 500 patients total.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Armenia
Enrollment target
~500 participants
Started
July 2023
Primary completion
July 2028
Last updated on clinicaltrials.gov in July 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tigran Aghabekyan
Nikomed Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.